Sight Sciences, Inc 8-K, filed Jun 10, 2022
Sight Sciences, Inc. (SGHT)
About this 8-K
Sight Sciences, Inc filed this 8-K on June 10, 2022, reporting on events of June 8, 2022.
Items reported
- Item 5.07: Shareholder vote results
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): |
(Exact name of Registrant as Specified in Its Charter)
(State or Other Jurisdiction |
(Commission File Number) |
(IRS Employer |
||
|
|
|
|
|
|
||||
|
||||
(Address of Principal Executive Offices) |
|
(Zip Code) |
||
Registrant’s Telephone Number, Including Area Code: |
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
Securities registered pursuant to Section 12(b) of the Act:
|
|
Trading |
|
|
|
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item 5.07. Submission of Matters to a Vote of Security Holders.
On June 8, 2022, Sight Sciences, Inc. (the “Company”) held its annual meeting of stockholders. A total of 33,302,882 shares of the Company’s common stock were present in person or represented by proxy at the meeting, representing approximately 70.0% of the Company’s common stock outstanding as of the April 11, 2022 record date. Set out below are the voting results for the proposals considered and voted upon at the meeting, each of which were described in the Company’s Definitive Proxy Statement filed with the Securities and Exchange Commission on April 29, 2022.
Item 1 – Election of three Class I directors to serve until the Company’s annual meeting of stockholders to be held in 2025 and until their respective successors have been duly elected and qualified.
|
|
Votes FOR |
|
|
Votes WITHHELD |
|
|
Broker Non-Votes |
|
|||
Paul Badawi |
|
|
29,040,248 |
|
|
|
2,414,236 |
|
|
|
1,848,398 |
|
Brenda Becker |
|
|
31,405,336 |
|
|
|
49,148 |
|
|
|
1,848,398 |
|
Erica Rogers |
|
|
27,239,339 |
|
|
|
4,215,145 |
|
|
|
1,848,398 |
|
Item 2 – Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2022.
Votes FOR |
|
|
Votes AGAINST |
|
|
Votes ABSTAINED |
|
|
Broker Non-Votes |
|||
|
33,168,884 |
|
|
|
115,476 |
|
|
|
18,522 |
|
|
0 |
Based on the foregoing votes, Paul Badawi, Brenda Becker and Erica Rogers were elected as Class I directors, and the appointment of Deloitte & Touche LLP as the Company’s independent public accounting firm for the fiscal year ending December 31, 2022 was duly ratified.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
Sight Sciences, Inc. |
|
|
|
|
Date: |
June 10, 2022 |
By: |
/s/ Paul Badawi |
|
|
|
President and Chief Executive Officer |